a School of Pharmacy , Shenyang Pharmaceutical University , Shenyang , PR China.
J Drug Target. 2018 Apr;26(4):289-295. doi: 10.1080/1061186X.2017.1379525. Epub 2017 Sep 21.
Doxorubicin (DOX), as an anthracycline, plays an important role in chemotherapy. But multidrug resistance (MDR) tremendously retards the anticancer effect of DOX and results in the failure of chemotherapy. Multifunctional micelles emerge as a valid strategy to load DOX by physical encapsulation or chemical binding to be delivered to cancer cells against MDR. In this review, mechanism of MDR of DOX is simply described. Multifunctional co-delivery micelles of DOX and main MDR modulators have been summarised in detail. DOX-loaded multifunctional polymeric micelles are also introduced to alleviate MDR of DOX, in which polymers act as MDR modulators.
多柔比星(DOX)作为一种蒽环类药物,在化疗中发挥着重要作用。但是,多药耐药(MDR)极大地削弱了 DOX 的抗癌作用,导致化疗失败。多功能胶束的出现为通过物理包封或化学结合将 DOX 递送至癌细胞以对抗 MDR 提供了一种有效的策略。在这篇综述中,简要描述了 DOX 的 MDR 机制。详细总结了 DOX 和主要 MDR 调节剂的多功能共递药胶束。还介绍了载 DOX 的多功能聚合物胶束以缓解 DOX 的 MDR,其中聚合物作为 MDR 调节剂。